Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

While anti‐cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio‐oncology units in Europe and a grow...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Anker, Markus S., Hadzibegovic, Sara, Lena, Alessia, Belenkov, Yury, Bergler‐Klein, Jutta, de Boer, Rudolf A., Farmakis, Dimitrios, von Haehling, Stephan, Iakobishvili, Zaza, Maack, Christoph, Pudil, Radek, Skouri, Hadi, Cohen‐Solal, Alain, Tocchetti, Carlo G., Coats, Andrew J.S., Seferović, Petar M., Lyon, Alexander R.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
ESC and HFA Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989292/
https://ncbi.nlm.nih.gov/pubmed/31884717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12551
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados